Results 201 to 210 of about 38,110 (241)
Some of the next articles are maybe not open access.

Neurofibromatosis Type I

2021
null Ryan W. Woods, MD, MPH   +1 more
openaire   +1 more source

Osteofibroma in type I neurofibromatosis.

Background: Neurofibromatosis type 1 is an autosomal dominant genetic disorder caused by a mutation in the NF1 gene on chromosome 17q11.2. There is insufficient evidence in the literature regarding the prevalence and incidence of neurofibromatosis type 1 in Hispanic populations, including Mexico. However, globally, the prevalence is estimated at 1 in 3,
Daniela Isabel Ramírez Jiménez M.D.   +4 more
openaire   +1 more source

Dural ectasia in neurofibromatosis type I

2020
Clinical History: A 12-year-old female patient is brought to the emergency room due to a fall. She is referred for further evaluation due to some findings in his clinical examination in the emergency and orthopedic evaluation.
openaire   +1 more source

Neurofibromatosis type 1 I. General overview

Journal of Neuroscience Research, 2000
M M, Lakkis, G I, Tennekoon
openaire   +2 more sources

An overview of real‐world data sources for oncology and considerations for research

Ca-A Cancer Journal for Clinicians, 2022
Lynne Penberthy   +2 more
exaly  

Ulnar hypoplasia and neurofibromatosis type I

The Journal of Pediatrics, 2004
Euthymia, Vargiami   +2 more
openaire   +2 more sources

Neurofibromatosis Type I: case report

Introduction: neurofibromatosis comprises three dominant inherited disorders, type I being the most common, relatively frequent, with a prevalence of 1 in 3500, with defining features and diverse manifestations, including a 5-10 times increased risk of cancer, with a cumulative risk of 40% at 50 years of age.
León Bermeo, Cristina Martha   +2 more
openaire   +1 more source

Lisch nodules in neurofibromatosis type I

Medicina Clínica (English Edition), 2019
Antonio, Ramos Suárez   +2 more
openaire   +2 more sources

Health insurance status and cancer stage at diagnosis and survival in the United States

Ca-A Cancer Journal for Clinicians, 2022
Jingxuan Zhao   +2 more
exaly  

Home - About - Disclaimer - Privacy